Peptide Research Library

Retatrutide is a triple-hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. This triple action suppresses appetite, increases energy expenditure, and enhances fat oxidation — producing the most significant weight loss results seen in any obesity trial to date.

BPC-157 is a stable gastric pentadecapeptide derived from human gastric juice. It accelerates healing by promoting angiogenesis (new blood vessel formation), upregulating growth factor expression, and modulating the nitric oxide system. Demonstrated effects across tendons, ligaments, muscles, gut lining, and nerve tissue.

TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring peptide found in all human cells. It promotes healing by sequestering actin, enabling cell migration to injury sites, reducing inflammation, and stimulating new blood vessel growth. Particularly effective for soft tissue injuries.

CJC-1295 is a modified growth hormone-releasing hormone (GHRH) analogue that stimulates pituitary GH release, while Ipamorelin is a selective ghrelin mimetic. Together they amplify natural growth hormone pulsatility without spiking cortisol or prolactin — providing sustained GH elevation for recovery, body composition, and sleep quality.

MOTS-c is a mitochondrial-derived peptide encoded within the 12S rRNA gene. It activates AMPK (the body's energy sensor), enhances glucose metabolism, improves insulin sensitivity, and mimics the metabolic benefits of exercise. Often called the "exercise mimetic peptide."

NAD+ is a coenzyme essential for cellular energy production, DNA repair, and sirtuin activation. Levels decline ~50% between ages 40–60, contributing to metabolic dysfunction and aging. Supplementation via NAD+ precursors (NMN/NR) restores cellular levels, improving mitochondrial function, insulin sensitivity, and cellular repair mechanisms.

HGH Fragment 176-191 is a modified segment of the human growth hormone molecule (amino acids 176–191). It isolates the fat-burning action of GH without triggering growth effects or blood sugar disruption. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (new fat formation), making it a targeted fat-loss peptide with no impact on insulin sensitivity or IGF-1 levels.

GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It declines with age — dropping by 60% between ages 20 and 60. It activates wound healing, stimulates collagen and glycosaminoglycan synthesis, promotes blood vessel growth, and has been shown to modulate over 4,000 human genes, resetting tissue gene expression towards a healthier, more youthful profile.

KLOW is a 4-in-1 recovery blend combining tissue repair (BPC-157, TB-500) with anti-inflammatory (KPV) and regenerative (GHK-Cu) peptides. Each component targets a different healing pathway — gut protection, cell migration, inflammation suppression, and collagen remodelling — for comprehensive recovery support.